Loading…
kubapharm.com unlawfully sold Schedule II controlled substance stimulants, including amphetamine products, directly to consumers over the internet in violation of the Ryan Haight Online Pharmacy Consumer Protection Act. The FDA determined that the company introduced misbranded amphetamine drug products into interstate commerce that circumvented regulatory safeguards, creating risks of contamination, counterfeit products, and inconsistent active ingredient levels. The violations were particularly concerning given the high abuse potential of Schedule II stimulants, their diversion as a primary source of nonmedical use among young adults and college students, and the rising mortality associated with psychostimulant-involved overdoses.